Neutralization serotyping of BK polyomavirus infection in kidney transplant recipients

PLoS Pathogens

Volumn 8, Issue 4, 2012, Pages

  Pastrana, Diana V ^a   Brennan, Daniel C ^b   Çuburu, Nicolas ^a   Storch, Gregory A ^b   Viscidi, Raphael P ^c   Randhawa, Parmjeet S ^d   Buck, Christopher B ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUTRALIZING ANTIBODY; VIRUS LIKE PARTICLE VACCINE; VIRUS ANTIBODY; VIRUS VACCINE;

ANIMAL EXPERIMENT; ANTIBODY DETECTION; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BK VIRUS; BK VIRUS INFECTION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GRAFT DYSFUNCTION; GRAFT FAILURE; GRAFT RECIPIENT; HUMAN; HUMAN TISSUE; KIDNEY DISEASE; KIDNEY GRAFT; MOUSE; NONHUMAN; SEROCONVERSION; SEROTYPING; VIRUS LIKE AGENT; VIRUS NEUTRALIZATION; ANIMAL; BAGG ALBINO MOUSE; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DISEASE MODEL; IMMUNOLOGY; KIDNEY TRANSPLANTATION; MALE; METABOLISM; METHODOLOGY; POLYOMAVIRUS INFECTION; RANDOMIZED CONTROLLED TRIAL; TIME; VACCINATION;

BK POLYOMAVIRUS; MUS;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; BK VIRUS; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; MALE; MICE; MICE, INBRED BALB C; POLYOMAVIRUS INFECTIONS; TIME FACTORS; VACCINATION; VIRAL VACCINES;

EID: 84861205288     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1002650     Document Type: Article

References (62)

1. Harrison JH, Merrill JP, Murray JE, (1956) Renal homotransplantation in identical twins. Surg Forum 6: 432-436.
2. Merrill JP, Murray JE, Harrison JH, Guild WR, (1956) Successful homotransplantation of the human kidney between identical twins. J Am Med Assoc 160: 277-282.
3. Calne RY, (1987) Cyclosporine and liver transplantation. Mt Sinai J Med 54: 465-466.
4. Kasiske BLZM, Craig JC, Ekberg H, Garvey CA, Green MD, et al. (2009) KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant 9 (Suppl 3): S1-155.
5. Purighalla R, Shapiro R, McCauley J, Randhawa P, (1995) BK virus infection in a kidney allograft diagnosed by needle biopsy. Am J Kidney Dis 26: 671-673.
6. Ramos E, Drachenberg CB, Portocarrero M, Wali R, Klassen DK, et al. (2002) BK virus nephropathy diagnosis and treatment: experience at the University of Maryland Renal Transplant Program. Clin Transpl pp. 143-153.
7. Hirsch HH, Brennan DC, Drachenberg CB, Ginevri F, Gordon J, et al. (2005) Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations. Transplantation 79: 1277-1286.
8. Hirsch HH, Steiger J, (2003) Polyomavirus BK. Lancet Infect Dis 3: 611-623.
9. Egli A, Infanti L, Dumoulin A, Buser A, Samaridis J, et al. (2009) Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors. J Infect Dis 199: 837-846.
10. Knowles WA, Pipkin P, Andrews N, Vyse A, Minor P, et al. (2003) Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40. J Med Virol 71: 115-123.
11. Boothpur R, Brennan DC, (2010) Human polyoma viruses and disease with emphasis on clinical BK and JC. J Clin Virol 47: 306-312.
12. Leung AY, Yuen KY, Kwong YL, (2005) Polyoma BK virus and haemorrhagic cystitis in haematopoietic stem cell transplantation: a changing paradigm. Bone Marrow Transplant 36: 929-937.
13. Cheerva AC, Raj A, Bertolone SJ, Bertolone K, Silverman CL, (2007) BK virus-associated hemorrhagic cystitis in pediatric cancer patients receiving high-dose cyclophosphamide. J Pediatr Hematol Oncol 29: 617-621.
14. Ginevri F, De Santis R, Comoli P, Pastorino N, Rossi C, et al. (2003) Polyomavirus BK infection in pediatric kidney-allograft recipients: a single-center analysis of incidence, risk factors, and novel therapeutic approaches. Transplantation 75: 1266-1270.
15. Bohl DL, Storch GA, Ryschkewitsch C, Gaudreault-Keener M, Schnitzler MA, et al. (2005) Donor origin of BK virus in renal transplantation and role of HLA C7 in susceptibility to sustained BK viremia. Am J Transplant 5: 2213-2221.
16. Bohl DL, Brennan DC, Ryschkewitsch C, Gaudreault-Keener M, Major EO, et al. (2008) BK virus antibody titers and intensity of infections after renal transplantation. J Clin Virol 43: 184-189.
17. Randhawa P, Bohl D, Brennan D, Ruppert K, Ramaswami B, et al. (2008) longitudinal analysis of levels of immunoglobulins against BK virus capsid proteins in kidney transplant recipients. Clin Vaccine Immunol 15: 1564-1571.
18. Bodaghi S, Comoli P, Bosch R, Azzi A, Gosert R, et al. (2009) Antibody responses to recombinant polyomavirus BK large T and VP1 proteins in young kidney transplant patients. J Clin Microbiol 47: 2577-2585.
19. Bohl DL, Brennan DC, (2007) BK virus nephropathy and kidney transplantation. Clin J Am Soc Nephrol 2 (Suppl 1): S36-46.
20. Yogo Y, Sugimoto C, Zhong S, Homma Y, (2009) Evolution of the BK polyomavirus: epidemiological, anthropological and clinical implications. Rev Med Virol 19: 185-199.
21. Luo C, Bueno M, Kant J, Martinson J, Randhawa P, (2009) Genotyping schemes for polyomavirus BK, using gene-specific phylogenetic trees and single nucleotide polymorphism analysis. J Virol 83: 2285-2297.
22. Knowles WA, Gibson PE, Gardner SD, (1989) Serological typing scheme for BK-like isolates of human polyomavirus. J Med Virol 28: 118-123.
23. Zheng HY, Nishimoto Y, Chen Q, Hasegawa M, Zhong S, et al. (2007) Relationships between BK virus lineages and human populations. Microbes Infect 9: 204-213.
24. Randhawa P, Kant J, Shapiro R, Tan H, Basu A, et al. (2011) The Impact of Genomic Sequence Variability on Quantitative Polymerase Chain Reaction Assays for the Diagnosis of Polyomavirus BK Infection. J Clin Microbiol 49: 4072-4076.
25. Schachtner T, Muller K, Stein M, Diezemann C, Sefrin A, et al. (2011) BKV-Specific Immunity Kinetics: A Predictor of Recovery From Polyomavirus BK-Associated Nephropathy. Am J Transplant 11: 2443-2452.
26. Stolt A, Sasnauskas K, Koskela P, Lehtinen M, Dillner J, (2003) Seroepidemiology of the human polyomaviruses. J Gen Virol 84: 1499-1504.
27. Pastrana DV, Buck CB, Pang YY, Thompson CD, Castle PE, et al. (2004) Reactivity of human sera in a sensitive, high-throughput pseudovirus-based papillomavirus neutralization assay for HPV16 and HPV18. Virology 321: 205-216.
28. Day PM, Kines RC, Thompson CD, Jagu S, Roden RB, et al. (2010) In vivo mechanisms of vaccine-induced protection against HPV infection. Cell Host Microbe 8: 260-270.
29. Kemp TJ, Hildesheim A, Safaeian M, Dauner JG, Pan Y, et al. (2011) HPV16/18 L1 VLP vaccine induces cross-neutralizing antibodies that may mediate cross-protection. Vaccine 29: 2011-2014.
30. Montefiori DC, Mascola JR, (2009) Neutralizing antibodies against HIV-1: can we elicit them with vaccines and how much do we need? Curr Opin HIV AIDS 4: 347-351.
31. Nabel GJ, Kwong PD, Mascola JR, (2011) Progress in the rational design of an AIDS vaccine. Philos Trans R Soc Lond B Biol Sci 366: 2759-2765.
32. Sasnauskas K, Bulavaite A, Hale A, Jin L, Knowles WA, et al. (2002) Generation of recombinant virus-like particles of human and non-human polyomaviruses in yeast Saccharomyces cerevisiae. Intervirology 45: 308-317.
33. Roldao A, Mellado MC, Castilho LR, Carrondo MJ, Alves PM, (2010) Virus-like particles in vaccine development. Expert Rev Vaccines 9: 1149-1176.
34. Buck CB, Pastrana DV, Lowy DR, Schiller JT, (2004) Efficient intracellular assembly of papillomaviral vectors. J Virol 78: 751-757.
35. Nakanishi A, Chapellier B, Maekawa N, Hiramoto M, Kuge T, et al. (2008) SV40 vectors carrying minimal sequence of viral origin with exchangeable capsids. Virology 379: 110-117.
36. Schowalter RM, Pastrana DV, Buck CB, (2011) Glycosaminoglycans and sialylated glycans sequentially facilitate merkel cell polyomavirus infectious entry. PLoS Pathog 7: e1002161.
37. Shaw G, Morse S, Ararat M, Graham FL, (2002) Preferential transformation of human neuronal cells by human adenoviruses and the origin of HEK 293 cells. FASEB J 16: 869-871.
38. Neu U, Maginnis MS, Palma AS, Stroh LJ, Nelson CD, et al. (2010) Structure-function analysis of the human JC polyomavirus establishes the LSTc pentasaccharide as a functional receptor motif. Cell Host Microbe 8: 309-319.
39. Stehle T, Gamblin SJ, Yan Y, Harrison SC, (1996) The structure of simian virus 40 refined at 3.1 A resolution. Structure 4: 165-182.
40. Dugan AS, Gasparovic ML, Tsomaia N, Mierke DF, O'Hara BA, et al. (2007) Identification of amino acid residues in BK virus VP1 that are critical for viability and growth. J Virol 81: 11798-11808.
41. Low JA, Magnuson B, Tsai B, Imperiale MJ, (2006) Identification of gangliosides GD1b and GT1b as receptors for BK virus. J Virol 80: 1361-1366.
42. Luo C, Hirsch HH, Kant J, Randhawa P, (2012) VP-1 quasispecies in human infection with polyomavirus BK. J Med Virol 84: 152-161.
43. Boldorini R, Veggiani C, Barco D, Monga G, (2005) Kidney and urinary tract polyomavirus infection and distribution: molecular biology investigation of 10 consecutive autopsies. Arch Pathol Lab Med 129: 69-73.
44. Hogan TF, Padgett BL, Walker DL, Borden EC, McBain JA, (1980) Rapid detection and identification of JC virus and BK virus in human urine by using immunofluorescence microscopy. J Clin Microbiol 11: 178-183.
45. Singh HK, Bubendorf L, Mihatsch MJ, Drachenberg CB, Nickeleit V, (2006) Urine cytology findings of polyomavirus infections. Adv Exp Med Biol 577: 201-212.
46. Randhawa PS, Khaleel-Ur-Rehman K, Swalsky PA, Vats A, Scantlebury V, et al. (2002) DNA sequencing of viral capsid protein VP-1 region in patients with BK virus interstitial nephritis. Transplantation 73: 1090-1094.
47. Anzivino E, Bellizzi A, Mitterhofer AP, Tinti F, Barile M, et al. (2011) Early monitoring of the human polyomavirus BK replication and sequencing analysis in a cohort of adult kidney transplant patients treated with basiliximab. Virol J 8: 407.
48. Baksh FK, Finkelstein SD, Swalsky PA, Stoner GL, Ryschkewitsch CF, et al. (2001) Molecular genotyping of BK and JC viruses in human polyomavirus-associated interstitial nephritis after renal transplantation. Am J Kidney Dis 38: 354-365.
49. Matsuda Y, Qazi Y, Iwaki Y, (2011) A rapid and efficient method BK polyomavirus genotyping by high-resolution melting analysis. J Med Virol 83: 2128-2134.
50. Tremolada S, Akan S, Otte J, Khalili K, Ferrante P, et al. (2010) Rare subtypes of BK virus are viable and frequently detected in renal transplant recipients with BK virus-associated nephropathy. Virology 404: 312-318.
51. Schiller JT, Lowy DR, (2010) Vaccines to prevent infections by oncoviruses. Annu Rev Microbiol 64: 23-41.
52. Sener A, House AA, Jevnikar AM, Boudville N, McAlister VC, et al. (2006) Intravenous immunoglobulin as a treatment for BK virus associated nephropathy: one-year follow-up of renal allograft recipients. Transplantation 81: 117-120.
53. Sharma AP, Moussa M, Casier S, Rehman F, Filler G, et al. (2009) Intravenous immunoglobulin as rescue therapy for BK virus nephropathy. Pediatr Transplant 13: 123-129.
54. Smith JM, Jordan SC, (2009) Intravenous immunoglobulin as treatment for BK virus: nephropathy. Pediatr Transplant 13: 11-13.
55. Brennan DC, Agha I, Bohl DL, Schnitzler MA, Hardinger KL, et al. (2005) Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction. Am J Transplant 5: 582-594.
56. Pastrana DV, Tolstov YL, Becker JC, Moore PS, Chang Y, et al. (2009) Quantitation of human seroresponsiveness to Merkel cell polyomavirus. PLoS Pathog 5: e1000578.
57. Nishimoto Y, Takasaka T, Hasegawa M, Zheng HY, Chen Q, et al. (2006) Evolution of BK virus based on complete genome data. J Mol Evol 63: 341-352.
58. Zhong S, Randhawa PS, Ikegaya H, Chen Q, Zheng HY, et al. (2009) Distribution patterns of BK polyomavirus (BKV) subtypes and subgroups in American, European and Asian populations suggest co-migration of BKV and the human race. J Gen Virol 90: 144-152.
59. Buck CB, Thompson CD, (2007) Production of papillomavirus-based gene transfer vectors. Curr Protoc Cell Biol Chapter 26: Unit 26.21.
60. McMillen J, Center MS, Consigli RA, (1975) Origin of the polyoma virus-associated endonuclease. J Virol 17: 127-131.
61. Garcea RL, Benjamin TL, (1983) Host range transforming gene of polyoma virus plays a role in virus assembly. Proc Natl Acad Sci U S A 80: 3613-3617.
62. Guex N, Peitsch MC, (1997) SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis 18: 2714-2723.